Brief: Shivalik Rasayan Says Centre For Drug Evaluation, China Has Acknowledged Drug Master File Of Bendamustine API
28/07/2023 07:37
July 28 (Reuters) - Shivalik Rasayan Ltd SIVA.NS :
* CENTRE FOR DRUG EVALUATION, CHINA HAS ACKNOWLEDGED DRUG
MASTER
FILE OF BENDAMUSTINE API
* PROCESS OF EVALUATIONS AND APPROVAL IS UNDERWAY
Source text for Eikon: ID:nBSE5LPzN7
Further company coverage: SIVA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shivalik Rasayan
See all newsBrief: Shivalik Rasayan Ltd March-Quarter Consol Net Profit 45.3 Million Rupees
Brief: Shivalik Rasayan Says US FDA Approved API Facility At Dahej
India's Shivalik Rasayan climbs on US FDA approval for facility
India's Shivalik Rasayan up as U.S. FDA completes inspection at Gujarat factory
Brief: Shivalik Rasayan Says US FDA Completes Inspection At API Facility At Dahej Unit